from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0193c/-

LFCtreatmentdescriptionclass of inhibitor

0.523

Amikacinug/mL Amikacintranslation

0.776

Cap5-10ug/mL Capreomycintranslation

1.905

Rox10-50 ug/mL Roxithromycintranslation

-0.659

SM2-5 ug/mL Streptomycintranslation

1.180

Tet5-10 ug/mL Tetracyclinetranslation

-0.058

Rif0.2-5ug/mL Rifampicintranscription

0.211

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.106

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.151

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.671

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.060

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.645

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.296

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.237

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.792

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.723

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.213

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.212

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.770

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.471

KCN5-20 ug/mL Potassium cyaniderespiration

3.720

NaN30.2-2 mM Sodium aziderespiration

0.145

Nigericin50 uM Nigericinrespiration

-0.116

TRC10-150 ug/mL Triclosanrespiration

-0.544

TRZ10-25 ug/mL Thioridazinerespiration

0.204

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.845

menadione6-10 ug/mL Menadionerespiration

0.152

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.037

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.247

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.795

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.852

NRP_1Non-replicating persistence stage 1dosRassociated

-0.094

Amp0.2mg/mL AmpicillincellWall

-0.173

Cephalexin20-100 ug/mL CephalexincellWall

-0.027

Cerulenin0.32-5 ug/mL CerulenincellWall

0.095

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.509

EMB10-20 ug/mL EthambutolcellWall

0.221

Eta12-40 ug/mL EthionamidecellWall

-0.217

INH0.2-0.4 ug/mL IsoniazidcellWall

0.077

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.325

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.414

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.539

BZA0.12 mg/mL BenzamidearomaticAmides

0.206

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.232

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.141

H2O24 mM hydrogen peroxideDNAdamaging

0.078

Levo10 ug/mL LevofloxacinDNAdamaging

0.223

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.564

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.099

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.324

UVUV-irradiationDNAdamaging

-0.610

ARP41-4 ug/mL Antitubercular compound ARP4?

0.021

Antimycin12.5-50 ug/mL Antimycin A?

-0.266

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.182

PA_110-50 ug/mL Antitubercular compound PA-1?

0.166

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.573

PA8240.2-2 ug/mL PA-824?

-0.737

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.347

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.206

Verapamil50 uM Verapamil?

0.052

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.220

methoxatin10-20 ug/mL Methoxatin?